$14.000
-0.399 (-2.85%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Iambic Therapeutics, Inc. Common Stock Stock?
Iambic Therapeutics, Inc. is not a good buy right now due to a significant 5-day price drop of 40.11% and a year-to-date decline of 10.88%. The stock has no earnings (P/E ratio of 0) and is trading at a high price-to-sales ratio of 38.1, indicating it may be overvalued. The lack of positive insider or hedge fund activity further suggests a lack of confidence in the stock's future performance.
IAM stock price ended at $14.00 on Tuesday, after losing -2.85%
Iambic Therapeutics, Inc. Common Stock (IAM) last closed at $14.7349997, gaining +5.25%. These facts feed the 1-day and 1-week IAM price prediction above.
Forecast Drivers
Iambic Therapeutics, Inc. Common Stock (IAM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
Seasonality analysis for IAM
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.